Expert Opinion on Drug Safety, Volume 14, Issue 6 (2015)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 6 (2015)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events
Daisuke Yabe, Rie Nishikino, Makiko Kaneko, Masahiro Iwasaki & Yutaka Seino
Pages: 795-800
Published online: 07 Apr 2015
AbstractforShort-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events | Full Text | References | PDF (311.5 KB)
  • 7167 Views
  • 66 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Are we waiting too long for the cardiovascular outcome trials with the glucagon-like peptide-1 receptor agonists?
Sheila A Doggrell (Senior Lecturer in Pharmacology) PhD DSc
Pages: 801-805
Published online: 20 Apr 2015
AbstractforAre we waiting too long for the cardiovascular outcome trials with the glucagon-like peptide-1 receptor agonists? | Full Text | References | PDF (146.3 KB)
  • 856 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Dronedarone and renal impairment: evaluation of Spanish postmarketing reports and review of literature
Mónica Tarapués MD, Gloria Cereza MD & Albert Figueras MD
Pages: 807-813
Published online: 12 May 2015
AbstractforDronedarone and renal impairment: evaluation of Spanish postmarketing reports and review of literature | Full Text | References | PDF (171.9 KB) | Supplemental
  • 214 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

A systematic review of patient medication error on self-administering medication at home
José Joaquín Mira, Susana Lorenzo, Mercedes Guilabert, Isabel Navarro & Virtudes Pérez-Jover
Pages: 815-838
Published online: 16 Mar 2015
AbstractforA systematic review of patient medication error on self-administering medication at home | Full Text | References | PDF (407 KB)
  • 2975 Views
  • 67 CrossRef citations
  • 0Altmetric
Glucocorticoid safety for treating rheumatoid arthritis
Linda A Rasch MSc, Irene EM Bultink, Lilian HD van Tuyl & Willem F Lems (Professor)
Pages: 839-844
Published online: 23 Mar 2015
AbstractforGlucocorticoid safety for treating rheumatoid arthritis | Full Text | References | PDF (240.9 KB)
  • 340 Views
  • 9 CrossRef citations
  • 0Altmetric
Safety of intravenous thrombolysis for acute ischemic stroke in specific conditions
Georgios Tsivgoulis MD FESO, Apostolos Safouris MD & Andrei V Alexandrov MD
Pages: 845-864
Published online: 06 Apr 2015
AbstractforSafety of intravenous thrombolysis for acute ischemic stroke in specific conditions | Full Text | References | PDF (579.8 KB) | Supplemental
  • 834 Views
  • 39 CrossRef citations
  • 0Altmetric
Giving rituximab in patients with occult or resolved hepatitis B virus infection: are the current guidelines good enough?
Jesse Civan & Hie Won Hann MD FASSLD
Pages: 865-875
Published online: 31 Mar 2015
AbstractforGiving rituximab in patients with occult or resolved hepatitis B virus infection: are the current guidelines good enough? | Full Text | References | PDF (234.2 KB)
  • 327 Views
  • 4 CrossRef citations
  • 0Altmetric
Drug-induced movement disorders
Dénes Zádori, Gábor Veres, Levente Szalárdy, Péter Klivényi & László Vécsei MD PhD DSc
Pages: 877-890
Published online: 16 May 2015
AbstractforDrug-induced movement disorders | Full Text | References | PDF (536.8 KB)
  • 742 Views
  • 22 CrossRef citations
  • 0Altmetric
Drug safety in acute migraine treatment
János Tajti (Associate Professor of Clinical Neurology) MD PhD, Zsófia Majláth (Resident in Clinical Neurology) MD, Délia Szok (Assistant Professor of Clinical Neurology) MD PhD, Anett Csáti (Resident in Clinical Neurology) MD PhD & László Vécsei (Member of the Hungarian Academy of Sciences) MD PhD DSc
Pages: 891-909
Published online: 15 Mar 2015
AbstractforDrug safety in acute migraine treatment | Full Text | References | PDF (1.1 MB)
  • 579 Views
  • 29 CrossRef citations
  • 0Altmetric
Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients
Janne Kaergaard Mortensen MD & Grethe Andersen MD DMSc
Pages: 911-919
Published online: 02 Apr 2015
AbstractforSafety of selective serotonin reuptake inhibitor treatment in recovering stroke patients | Full Text | References | PDF (227.3 KB)
  • 623 Views
  • 24 CrossRef citations
  • 0Altmetric
Selective estrogen receptor modulators in clinical practice: a safety overview
Amanda J Ellis (Senior Director, Safety Surveillance and Risk Management) BSc MBBS MRCP(UK) MFPM, Vicky M Hendrick, Robert Williams & Barry S Komm
Pages: 921-934
Published online: 02 May 2015
AbstractforSelective estrogen receptor modulators in clinical practice: a safety overview | Full Text | References | PDF (275.5 KB)
  • 1357 Views
  • 79 CrossRef citations
  • 0Altmetric

Position Paper

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
This paper is also published in parallel in Archives of Medical Science [Banach M, Rizzo M, Toth PP, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015; 11(1): 1–23]
Maciej Banach (Professor, Head) MD PhD FNLA FAHA FESC FASA FRSPH, Manfredi Rizzo, Peter P Toth, Michel Farnier, Michael H Davidson, Khalid Al-Rasadi, Wilbert S Aronow, Vasilis Athyros, Dragan M Djuric, Marat V Ezhov, Robert S Greenfield, G Kees Hovingh, Karam Kostner, Corina Serban, Daniel Lighezan, Zlatko Fras, Patrick M Moriarty, Paul Muntner, Assen Goudev, Richard Ceska, Stephen J Nicholls, Marlena Broncel, Dragana Nikolic, Daniel Pella, Raman Puri, Jacek Rysz (Professor, Head) , Nathan D Wong, Laszlo Bajnok, Steven R Jones, Kausik K Ray & Dimitri P Mikhailidis
Pages: 935-955
Published online: 24 Apr 2015
AbstractforStatin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel | Full Text | References | PDF (468.4 KB)
  • 1233 Views
  • 99 CrossRef citations
  • 0Altmetric

Drug Safety Evaluation

Safety of pembrolizumab for the treatment of melanoma
Juan Martin-Liberal, Tiana Kordbacheh & James Larkin
Pages: 957-964
Published online: 30 Apr 2015
AbstractforSafety of pembrolizumab for the treatment of melanoma | Full Text | References | PDF (197.8 KB)
  • 1614 Views
  • 22 CrossRef citations
  • 0Altmetric
Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids
Emanuela Tafi MD, Carolina Scala MD, Umberto Leone Roberti Maggiore MD, Nicolò Bizzarri MD, Massimo Candiani, Pier Luigi Venturini MD & Simone Ferrero MD PhD
Pages: 965-977
Published online: 14 Mar 2015
AbstractforDrug safety evaluation of ulipristal acetate in the treatment of uterine fibroids | Full Text | References | PDF (315.2 KB)
  • 456 Views
  • 12 CrossRef citations
  • 0Altmetric
Drug safety evaluation of apremilast for treating psoriatic arthritis
Swapna Busa & Arthur Kavanaugh
Pages: 979-985
Published online: 31 Mar 2015
AbstractforDrug safety evaluation of apremilast for treating psoriatic arthritis | Full Text | References | PDF (255.8 KB)
  • 994 Views
  • 18 CrossRef citations
  • 0Altmetric
Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events
Reena Khanna (Assistant Professor) MD & Brian G Feagan (Professor) MD
Pages: 987-997
Published online: 29 Mar 2015
AbstractforSafety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events | Full Text | References | PDF (265.4 KB)
  • 713 Views
  • 19 CrossRef citations
  • 0Altmetric

Meeting Highlights

14th Annual Meeting of the Safety Pharmacology Society: threading through scientific sessions for originality and novelty
Icilio Cavero PhD
Pages: 999-1008
Published online: 15 Apr 2015
Abstractfor14th Annual Meeting of the Safety Pharmacology Society: threading through scientific sessions for originality and novelty | Full Text | References | PDF (214.6 KB)
  • 190 Views
  • 3 CrossRef citations
  • 0Altmetric

Erratum

Correction
Erratum
Page: 1009
Published online: 28 Apr 2015
CitationforErratum | Full Text | PDF (31.6 KB)
  • 427 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Further Readings

Related articles
Page: 1
Published online: 16 May 2015
CitationforRelated articles | Full Text | PDF (84.6 KB)
  • 54 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles